Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.

by Ludovic Belle, Gilles Fransolet, Joan Somja, Marilène Binsfeld, Philippe Delvenne, Pierre Drion, Muriel Hannon, Yves Beguin, Grégory Ehx, Frédéric Baron
Published 2016-01-01

Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects

by Grégory Ehx, Gilles Fransolet, Laurence de Leval, Stéphanie D'Hondt, Sophie Lucas, Muriel Hannon, Loïc Delens, Sophie Dubois, Pierre Drion, Yves Beguin, Stéphanie Humblet-Baron, Frédéric Baron
Published 2017-05-01

Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease

by Gilles Fransolet, Grégory Ehx, Joan Somja, Loïc Delens, Muriel Hannon, Joséphine Muller, Sophie Dubois, Pierre Drion, Jo Caers, Stéphanie Humblet-Baron, Philippe Delvenne, Yves Beguin, Giuseppina Conteduca, Frédéric Baron
Published 2016-07-01

Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice

by Grégory Ehx, Joan Somja, Hans-Jörg Warnatz, Caroline Ritacco, Muriel Hannon, Loïc Delens, Gilles Fransolet, Philippe Delvenne, Joséphine Muller, Yves Beguin, Yves Beguin, Hans Lehrach, Ludovic Belle, Stéphanie Humblet-Baron, Stéphanie Humblet-Baron, Frédéric Baron, Frédéric Baron
Published 2018-08-01